Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...
The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...
Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...
New blood test could show if prostate cancer treatment is failing - The discovery could lead to personalised treatments for ...
Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...
UK experts have recommended that only a small group of high-risk men should be eligible for regular testing for prostate ...
NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
UK National Screening Committee rejects call from Olympic legend Sir Chris Hoy to offer PSA test to all men at higher risk of ...
The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...